Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemiaElena J. Orlando, Wendy Winckler, Xia Han et al.|Nature Medicine|2018Cited by 577
PTEN Expression, Not Mutation Status in <i>TSC1, TSC2</i>, or <i>mTOR</i>, Correlates with the Outcome on Everolimus in Patients with Renal Cell Carcinoma Treated on the Randomized RECORD-3 TrialMartin H. Voss, Robert J. Motzer, Jianning Xu et al.|Clinical Cancer Research|2018Cited by 38